Skip to main content
Caplight Logo









Pathway Bio

Pathway Bio

Private
LondonHealthcare & Life Scienceshttps://www.pwbio.ai/

Last Round

Pre Seed

Oct 13, 2025

Total Funding Raised

$350,000

Company Overview

Pathway Bio is a healthtech company that provides a functional precision medicine platform to predict and validate cancer treatment outcomes using multiomic profiling, AI-driven prediction, and ex vivo microcancer technology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

drug discoverycomputational biologyprecision medicineai drug discoverymulti-omic profilingtherapeutic target identificationclinical decision supportbiotech aipredictive modelingex vivo testingin silico drug discoveryagentic workflowsbiotech platformdrug development pipelinelab-as-a-service

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pathway Bio Comparables

Compare Pathway Bio with similar companies based on industry and business-model similarity.

Pathway Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deep Origin
81%
AI Vivo
77%
Insilico Medicine
76%

Pathway Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedOct 13, 2025
AcceleratorJan 1, 2025

Key People

Founding team and executive leadership

Bobby Kaura

Founder & CEO

Founding Team

Pathway Bio Investors

Notable investors and investment history

Pathway Bio investors
InvestorRounds
KQ LabsAccelerator
LifeArcAccelerator
Cancer Research HorizonsAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    $50K raised from LifeArc, Cancer Research Horizons, and KQ Labs.

Pathway Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pathway Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pathway Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range3
Year Founded2025
Last FundingOct 13, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?